John W.G. van Putten

Author

Also Known As

John W G van Putten, John W. G. van Putten, John W.G Van Putten, John W.G van Putten, John W.G. Van Putten, John W.G. van Putten

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

University of Groningen University Medical Center Groningen Martini Ziekenhuis OLVG

About

John W.G. van Putten is an author at University of Groningen specializing in radiation oncology, lung cancer, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	118
2	Molecular Biology	1	1	81
3	Pharmacology	1	1	37
4	Cancer Therapeutics	1	1	37
5	Genome Editing	1	1	81

John W.G. van Putten

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Preoperative Staging of Non–Small-Cell Lung Cancer with Positron-Emission Tomography Remge M. Pieterman, John W.G. van Putten, J. J. Meuzelaar, New England Journal of Medicine	2000	1.1K
Paclitaxel and Carboplatin in the Treatment of Small-Cell Lung Cancer Patients Resistant to Cyclophosphamide, Doxorubicin, and Etoposide: A Non–Cross-Resistant Schedule Harry J.M. Groen, Eelco Fokkema, Bonne Biesma, Journal of Clinical Oncology	1999	114
Randomized, Placebo-Controlled Phase III Study of Docetaxel Plus Carboplatin With Celecoxib and Cyclooxygenase-2 Expression As a Biomarker for Patients With Advanced Non–Small-Cell Lung Cancer: The NVALT-4 Study Harry J.M. Groen, Hannie Sietsma, Andrew Vincent, Journal of Clinical Oncology	2011	107
Selective targeting of homologous DNA recombination repair by gemcitabine Floris M Wachters, John W.G. van Putten, Jan Gerard Maring, International Journal of Radiation OncologyBiologyPhysics Genome InstabilitySelective TargetingMolecular BiologyGene DeliveryMedicine	2003	81
Comparison of (11)C-choline and (18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancer. Remge M. Pieterman, Tjin H. Que, Philip H. Elsinga, PubMed	2002	77
A Phase I study of gemcitabine with concurrent radiotherapy in stage III, locally advanced non-small cell lung cancer. John W.G. van Putten, A. Price, A.H.D. van der Leest, PubMed	2003	50
Activity of single-agent gemcitabine as second-line treatment after previous chemotherapy or radiotherapy in advanced non-small-cell lung cancer John W.G. van Putten, Paul Baas, Henk Codrington, Lung Cancer Second-line TreatmentMedicineSingle-agent GemcitabinePharmacologyPrevious Chemotherapy	2001	37
Common and Rare EGFR and KRAS Mutations in a Dutch Non-Small-Cell Lung Cancer Population and Their Clinical Outcome Gerald S. M. A. Kerner, Ed Schuuring, Johanna Sietsma, PLoS ONE	2013	34
Determination of Ifosfamide, 2- and 3-Dechloroethyifosfamide Using Gas Chromatography With Nitrogen-Phosphorus or Mass Spectrometry Detection Thomas Kerbusch, Marie-Jos Jeuken, Jamila Derraz, Therapeutic Drug Monitoring	2000	21
Iris Metastasis in Small-Cell Lung Carcinoma Anke W.J. Roenhorst, A.C.M. van den Bergh, John W.G. van Putten, Journal of Thoracic Oncology Malignant DiseaseRadiation OncologyLung CancerIris Metastasis	2007	12

Page 1